Characterization of class IIa bacteriocin resistance in Enterococcus faecium

Kathryn Geldart, Yiannis N. Kaznessis

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Vancomycin-resistant enterococci, particularly resistant Enterococcus faecium, pose an escalating threat in nosocomial environments because of their innate resistance to many antibiotics, including vancomycin, a treatment of last resort. Many class IIa bacteriocins strongly target these enterococci and may offer a potential alternative for the management of this pathogen. However, E. faecium's resistance to these peptides remains relatively uncharacterized. Here, we explored the development of resistance of E. faecium to a cocktail of three class IIa bacteriocins: enterocin A, enterocin P, and hiracin JM79. We started by quantifying the frequency of resistance to these peptides in four clinical isolates of E. faecium. We then investigated the levels of resistance of E. faecium 6E6 mutants as well as their fitness in different carbon sources. In order to elucidate the mechanism of resistance of E. faecium to class IIa bacteriocins, we completed whole-genome sequencing of resistant mutants and performed reverse transcription-quantitative PCR (qRT-PCR) of a suspected target mannose phosphotransferase (ManPTS). We then verified this ManPTS's role in bacteriocin susceptibility by showing that expression of the ManPTS in Lactococcus lactis results in susceptibility to the peptide cocktail. Based on the evidence found from these studies, we conclude that, in accord with other studies in E. faecalis and Listeria monocytogenes, resistance to class IIa bacteriocins in E. faecium 6E6 is likely caused by the disruption of a particular ManPTS, which we believe we have identified.

Original languageEnglish (US)
Article numbere02033-16
JournalAntimicrobial agents and chemotherapy
Issue number4
StatePublished - Apr 2017

Bibliographical note

Funding Information:
We thank Gary Dunny and Patricia Ferrieri from the University of Minnesota Medical School for supplying clinical isolates of E. faecium with varied spectra of antibiotic resistance for these studies. We also thank Kevin Silverstein and Jon Badalamenti for their assistance with the genome sequencing portion of the study. The project was funded by grants from the National Institutes of Health (GM111358) and from the National Science Foundation (CBET-1412283).

Publisher Copyright:
© 2017 American Society for Microbiology. All Rights Reserved.


  • Antibiotic resistance
  • Bacteriocins
  • Enterococcus


Dive into the research topics of 'Characterization of class IIa bacteriocin resistance in Enterococcus faecium'. Together they form a unique fingerprint.

Cite this